Table II.
Significantly altered pathways in the gene set enrichment analysis.
A, Lactate group | ||||
---|---|---|---|---|
Term | ES | NES | P-value | FDR |
Cell cycle | −0.47 | −1.53 | <0.01 | 0.06 |
Oxidative phosphorylation | −0.41 | −1.35 | 0.04 | 0.13 |
B, Hypoxia group | ||||
Term | ES | NES | P-value | FDR |
Hedgehog signaling pathway | 0.60 | 1.66 | 0.01 | 0.04 |
Oxidative phosphorylation | −0.40 | −1.39 | 0.02 | 0.14 |
C, Hypoxia-lactate group | ||||
Term | ES | NES | P-value | FDR |
mTOR signaling pathway | 0.54 | 1.77 | 0.01 | 0.01 |
Glycolysis gluconeogenesis | 0.49 | 1.59 | 0.01 | 0.04 |
Hedgehog signaling pathway | 0.48 | 1.54 | 0.01 | 0.04 |
Oxidative phosphorylation | −0.41 | −1.35 | 0.05 | 0.12 |
Cell cycle | −0.44 | −1.41 | 0.02 | 0.15 |
MAPK signaling pathway | 0.28 | 1.18 | 0.05 | 0.19 |
ES, enrichment score; NES, normalized ES; FDR, false discovery rate; MAPK, mitogen-activated protein kinase.